Related Experiment Video
Updated: Aug 8, 2026

Drug Treatment and In Vivo Imaging of Osteoblast-Osteoclast Interactions in a Medaka Fish Osteoporosis Model
Published on: January 1, 2017
Identification and characterization of endothelin receptors on rat osteoblastic osteosarcoma cells: down-regulation
1Department of Renal Pharmacology, SmithKline Beecham Pharmaceuticals, King of Prussia, Pennsylvania 19406.
Abstract:
Endothelins (ETs) (ET-1, ET-2, and ET-3), a family of 21-amino acid peptides, mediate a host of biological responses by binding to specific cell surface receptors termed ETA and ETB. Because a role for ET in bone remodeling has been suggested, the present study was undertaken (a) to characterize ET receptors and their responses in the rat osteosarcoma cell line ROS 17/2.8 and (b) to study their regulation by 1,25-dihydroxy-vitamin D3. Binding studies using 125I-ET-1 (a nonselective agonist) and 125I-IRL-1620 (an ETB receptor-selective agonist) indicated that these cells display high affinity ETA and ETB receptors in the ratio of 3:1. Addition of ET-1 or sarafotoxin 6c to myo-[3H]inositol-labeled cells resulted in an increase in inositol phosphate accumulation as well as in intracellular Ca2+ release, suggesting that these receptors are coupled to phospholipase C. In addition, ET-1 but not sarafotoxin 6c induced a modest increase in the expression of osteocalcin protein that was completely blocked by BQ123 (an ETA receptor-selective antagonist), indicating that activation of ETA receptors plays a role in the induction of osteocalcin. Treatment of ROS osteoblasts with 10 nM 1,25-dihydroxy-vitamin D3 for 14 hr resulted in a significant (> 50%) decrease in 125I-ET-1 and 125I-IRL-1620 binding. This decrease in binding was shown to be due to a decrease in the number of ET receptors, with no change in affinity. Although both ETA and ETB receptors were down-regulated in response to 1,25-dihydroxy-vitamin D3, only ETA receptor mRNA levels were significantly decreased, with very little change in ETB mRNA levels. These data indicate that ROS osteoblasts display both ETA and ETB receptors that are functional. Induction of osteocalcin was primarily mediated by ETA receptors, and these receptors were also down-regulated at the mRNA level by 1,25-dihydroxy-vitamin D3.
Insights
This study found that rat osteosarcoma cells have functional endothelin receptors (ETA and ETB). 1,25-dihydroxy-vitamin D3 down-regulates these receptors, particularly ETA, impacting osteocalcin expression.
Area of Science:
- Biochemistry
- Molecular Biology
- Endocrinology
Background:
- Endothelins (ETs) are peptides involved in various biological processes.
- A role for ETs in bone remodeling is suggested, necessitating further investigation.
- The rat osteosarcoma cell line ROS 17/2.8 is a model for studying bone cells.
Purpose of the Study:
- To characterize endothelin receptors (ETA and ETB) and their signaling pathways in ROS 17/2.8 cells.
- To investigate the regulation of these receptors by 1,25-dihydroxy-vitamin D3.
- To determine the role of ETA receptors in osteocalcin expression.
Main Methods:
- Radioligand binding assays using 125I-ET-1 and 125I-IRL-1620 to quantify ETA and ETB receptors.
- Measurement of inositol phosphate accumulation and intracellular Ca2+ release to assess receptor signaling.
- Western blot analysis to detect osteocalcin protein expression.
- Quantitative analysis of ETA and ETB receptor mRNA levels.
Main Results:
- ROS 17/2.8 cells express high-affinity ETA and ETB receptors (3:1 ratio).
- ET-1 and sarafotoxin 6c activate phospholipase C, leading to increased inositol phosphate and Ca2+ release.
- ET-1, acting via ETA receptors, induces osteocalcin protein expression.
- 1,25-dihydroxy-vitamin D3 significantly down-regulates both ETA and ETB receptor binding, primarily by reducing receptor number.
- 1,25-dihydroxy-vitamin D3 decreases ETA receptor mRNA levels but has minimal effect on ETB mRNA levels.
Conclusions:
- ROS osteoblasts possess functional ETA and ETB receptors coupled to phospholipase C.
- ETA receptor activation is crucial for ET-1-induced osteocalcin expression.
- 1,25-dihydroxy-vitamin D3 down-regulates endothelin receptors at both protein and mRNA levels, with a more pronounced effect on ETA receptors.
More Related Videos
08:55Isolation and Characterization of Primary Rat Valve Interstitial Cells: A New Model to Study Aortic Valve Calcification
Published on: November 20, 2017
06:47Isolation of Mesenchymal Stem Cells from Human Alveolar Periosteum and Effects of Vitamin D on Osteogenic Activity of Periosteum-derived Cells
Published on: May 4, 2018
Related Concept Videos
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
Regulation of Angiogenesis and Blood Supply